Loomis Sayles & Co. L P Purchases New Shares in Select Medical Holdings Co. (NYSE:SEM)

Loomis Sayles & Co. L P bought a new position in shares of Select Medical Holdings Co. (NYSE:SEM) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 278,469 shares of the health services provider’s stock, valued at approximately $9,710,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SEM. Hexagon Capital Partners LLC grew its holdings in Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after acquiring an additional 645 shares during the last quarter. Transcendent Capital Group LLC acquired a new stake in shares of Select Medical in the second quarter valued at approximately $35,000. Canada Pension Plan Investment Board bought a new position in Select Medical in the 2nd quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new position in Select Medical in the 2nd quarter valued at $60,000. Finally, GAMMA Investing LLC boosted its position in Select Medical by 52.8% in the 2nd quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock valued at $70,000 after buying an additional 685 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Stock Performance

Shares of SEM stock opened at $20.35 on Thursday. The stock has a 50-day moving average of $34.69 and a 200-day moving average of $34.90. Select Medical Holdings Co. has a one year low of $20.00 and a one year high of $40.98. The stock has a market cap of $2.63 billion, a PE ratio of 9.51, a price-to-earnings-growth ratio of 1.73 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same period last year, the firm posted $0.46 earnings per share. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. As a group, sell-side analysts expect that Select Medical Holdings Co. will post 2.16 earnings per share for the current year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were issued a $0.125 dividend. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 2.46%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Analysts Set New Price Targets

SEM has been the topic of several research reports. Bank of America began coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Thursday, November 21st. Royal Bank of Canada increased their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Select Medical currently has a consensus rating of “Hold” and an average target price of $40.75.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.